51.0
Matinas BioPharma Holdings, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
34.5
FY23:
15.5
FY24:
8.03
FY25:
4.08
(positive)
Change from FY21 to FY25
millions USD
FY21:
10.3
FY22:
10.3
FY23:
9.56
FY24:
4.62
FY25:
3.13
Total assets
Change from FY21 to FY25
millions USD
FY21:
61.3
FY22:
44.8
FY23:
25.1
FY24:
12.6
FY25:
7.21
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
4.35
FY22:
4.29
FY23:
2.62
FY24:
2.67
FY25:
1.46
(negative)
Change from FY21 to FY25
millions USD
FY21:
4.48
FY22:
3.90
FY23:
3.24
FY24:
2.39
FY25:
0.92
(positive)
Change from FY21 to FY25
millions USD
FY21:
52.5
FY22:
36.6
FY23:
19.2
FY24:
7.59
FY25:
4.83
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
61.3
FY22:
44.8
FY23:
25.1
FY24:
12.6
FY25:
7.21
All amounts in millions USD